Skip to main content
. Author manuscript; available in PMC: 2018 Nov 28.
Published in final edited form as: J Control Release. 2017 Sep 20;266:129–139. doi: 10.1016/j.jconrel.2017.09.024

Figure 5. Comparison of cell phenotypes cultured in T-MOC and xenograft.

Figure 5

(A) Flow cytometry of CD44 and CD24 expression of cells cultured in different conditions. (B) Cellular phenotype change of xenografted MCF-7 and MDA-MB-231 cells after doxorubicin treatments. (C) Tumor progression during 2.0mg/kg doxorubicin treatments.